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Positron Emission Tomography (PET) is a valuable clinical, research, and 
diagnostic technique for human and animal organ imaging.  The current market for PET 
in the United States is $500 million per year and is projected to be $5.4 billion per year 
globally by 2015.  To synthesize labeled radiotracers, we are most interested in using 
18
F 
as the isotope of choice because it is a nearly ideal positron emitting radionuclide.   
Electron-rich aromatic substrates can be particularly difficult to fluorinate.  We 
show that reductive elimination of I(III) diaryliodonium salts provide increased 
fluorination of electron-rich aromatic substrates.  Modest yields of fluorinated product 
were initially observed due to the lack of regioselectivity in the reductive elimination 
process.  It seemed clear that a better directing group would be needed if extremely 
electron-rich rings are to be fluorinated in high chemical (or radiochemical) yields using 
diaryliodonium salts.  The use of [2.2]paracyclophane as a directing ligand has been 
shown by computational and experimental data to provide an increase in steric demand 
above the plane of the aromatic ring; therefore, destabilizing a reductive elimination 
transition state. This effect is sufficiently large to provide stereoelectronic control of 
unidirectional reductive elimination (SECURE) for most nucleophiles; however, benzyne 
chemistry was observed when fluorine and 2,2,2-trifluoroethoxide were used as 
nucleophiles.   
To address the benzyne issue, we have shown that the choice of a judiciously 
substituted cyclophane substituent on I(III) can provide perfect regioselectivity for 
reductive elimination of iodocyclophanes and fluorination of electron-rich arenes.  This 
work constitutes the first example of regiospecific fluorination of electron-rich aromatic 
rings using diaryliodonium fluorides.  We believe this discovery paves the way for the 
synthesis of highly elaborated radiotracers from Ar2IF salts. 
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CHAPTER ONE 
Introduction 
 
1.1  Background 
Positron Emission Tomography (PET) is a valuable clinical, research, and 
diagnostic technique for human and animal organ imaging.  The current market for PET 
in the United States is $500 million per year and is projected to be $5.4 billion per year 
globally by 2015.
1
  The imaging process of PET begins when a labeled radioactive tracer 
is injected into a patient.  The 
18
F nucleus in the radioactive tracer undergoes radioactive 
decay (p
+
  n + B+) and emits a positron.  This emitted positron collides with an electron 
in the environment resulting in an annihilation event.  The destruction of matter results in 
the production of gamma radiation.  The gamma radiation is then picked up by spatially 
addressable scintillation detectors surrounding the patient, and an image is then 
Table 1-1 List of commonly used position emitters 
12 
 
reconstructed on a computer screen of a targeted area or organ.   
Commonly used positron emitters include 
11
C, 
13
N, 
15
O, 
18
F, 
68
Ga, and 
124
I (Table 
1-1).  We are most interested in 
18
F because it is a nearly ideal positron emitting 
radionuclide.  Attractive characteristics of 
18
F include: 1) It has a relatively long half life 
(109.77 min.), which allows ample time for the synthesis and transfer of radiotracers 
from a cyclotron facility to PET imaging centers.  2) The positron is emitted with 
relatively low kinetic energy (242 keV) and short range in tissue, and thus is captured 
proximal to the decay event.  This leads to relatively high resolution (1 min.)  3) 
18
F can 
be produced in large amounts in a single cyclotron run (>10 Ci).  4) Radiochemical yields 
for 
18
F PET tracers can be extremely high. 
 
Figure 1-1  Generation of 
18
F 
18
F is generated in a particle accelerator (Figure 1-1).  The most effective 
generation route of 
18
F is through bombardment of H2
18
O with protons from the 
cyclotron.  Once 
18
F is generated, it is captured on an ion-exchange column, and liberated 
from the column with a salt solution, such as tetramethylammonium hydroxide 
(TMAOH), and a nucleophilic fluoride source tetramethylammonium fluoride (TMAF) is 
obtained.  This TMA
18
F can now be introduced to a tracer of interest.  
13 
 
 
Figure 1-2 Examples of PET radiotracers 
The most widely used 
18
F PET radiotracer is 2-[
18
F]Fluoro-2-deoxy-D-glucose 
([
18
F]FDG).  It is widely used because of its ability to be produced in high yields and 
shorter reaction times.  [
18
F]FDG is synthesized by nucleophilic fluorination using 
mannose triflate as a precursor and Kryptofix 222 KF (Figure 1-3) or 
tetrabutylammonium salts (TBA).  There are drawbacks to using [
18
F]FDG as well.  
[
18
F]FDG is rather widely distributed in the body, so identification of exceptionally 
metabolizing active tissues can be a problem.  To address this issue, many different 
radiotracers need to be efficiently synthesized in order to target specific areas of interest 
throughout the body.  A large number of these desired radiotracers require fluorination on 
an aromatic substrate (Figure 1-2). 
 
Figure 1-3  Structure of Kryptofix 222 KF 
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Two methods to prepare fluorinated aromatic radiotracers with 
18
F include 
nucleophilic or electrophilic aromatic substitution.  Nucleophilic aromatic fluorination is 
most commonly carried out with Kryptofix 222 KF or CsF.  Nucleophilic fluoride, which 
has a moderate reactivity and high specific activity, is typically used for fluorination of 
electron-deficient arenes.  Electrophilic fluorine is most commonly introduced through 
[
18
F]F2, or [
18
F]AcOF.  Electrophilic fluorine is highly reactive and carrier added (
19
F 
present), which is results in a low specific activity (amount of gamma radiation 
produced).  
Electron-rich aromatic substrates can be particularly difficult to fluorinate.  
Nucleophilic fluorination of electron-rich arenes can only be accomplished by inclusion 
of an activating group that is subsequently removed; these multistep transformations are 
sometimes inefficient for PET chemistry. Direct fluorination of electron rich aromatic 
rings with [
18
F]F2 generally yields a mixture of regioisomers.  Fluorodemetalation 
(usually fluorodestannylation) with [
18
F]F2 or [
18
F]AcOF can provide control of 
regiochemistry, however; metal toxicity is a concern and the fluorinated drug is still 
produced with relative low specific activity.  Our goal is to develop a reliable, low-cost, 
easy-to-use system for on-demand radiolabeling, with the flexibility to develop new 
probes. 
15 
 
 
Scheme 1-1 Pd-catalyzed aromatic fluorination utilizing tBuBrettPhos as the ligand 
Transition metal catalyzed fluorinations are one potential solution to fluorinate 
electron-rich aromatic substrates.
2
  Recently, Buchwald and co-workers developed 
extremely hindered phosphine ligands that permit catalytic fluorination from fluoro-
Pd(II) complexes for late stage incorporation of fluoride into electron-rich aromatic 
substrates (Scheme 1-1).
2
  However, this approach is inefficient for PET applications for 
a number of reasons.  The long reaction time (12 hours) and requirement for excess 
fluorinating agent (6 equiv. CsF) are clearly incompatible with the demands of 
radiotracer synthesis.  In PET chemistry, the fluorinating agent is available in tiny 
amounts (10 ng / Curie).  Regioisomers were identified as products during Buchwald’s 
Pd-catalyzed fluorination of aryl triflates.  Although no definitive explanation was given 
for the presence of regioisomers, the formation of benzyne was suspected to play a role in 
the formation of 3-fluoroanisole. 
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1.2  Fluorination via reductive elimination using diaryliodonium salts  
 
While transition metal catalyzed fluorination appears to be a promising approach, 
given that the key step in the process for 
18
F chemistry is a reductive elimination, we 
thought higher valent metal ions would show more promise.  A difficulty with transition 
metals in high oxidation states is the potential for binding more than one anionic ligand.  
Since fluoride is generally extremely recalcitrant in reductive eliminations, we 
investigated stable aryl complexes that bound only one anion.  It became clear that the 
conceptual framework used in the optimization of organometallic reactions is directly 
applicable to iodine chemistry: I(III) acts as a highly electronegative transition metal ion 
(Figure 1-4). 
 
Figure 1-4  Iodine as a transition metal ion 
 There is a key difference in the reactivity of I(III) complexes and the late 
transition metal ions.  While Ar2M(X)n complexes generally undergo reductive 
elimination of biaryls, Ar2IX compounds form Ar-F and Ar-I upon reductive elimination.  
This different reactivity pattern is a direct consequence of the greater electronegativity of 
iodine and the tremendously increased stability of Ar-I(I) complexes compared to Ar-M 
complexes.  This different reactivity manifold is a substantial advantage for I(III) 
chemistry. 
17 
 
 
Scheme 1-2 One-step methods to n.c.a. 1-bromo-4-[18F]fluorobenzene.
3
 
Applications using iodine in diaryliodonium salts for fluorination of aromatic 
substrates has been known since the 1980’s.4-6  This synthetic strategy was first 
introduced to 
18
F PET radiotracers by Pike and co-workers in 1995.
7
  Prior to our work, 
the thermal decomposition reactions were performed exclusively in polar solvents, such 
as acetonitrile (CH3CN).  An example shown in Scheme 1-2 indicates that reductive 
elimination of diaryliodonium salts offers a highly competitive method to fluorinate 
unactivated aromatic compounds; The convenience of a one-step reaction to achieve a 
high radiochemical yield of product is an added bonus.  Six different methods (Scheme 1-
18 
 
2) to prepare 1-bromo-4-[
18
F]fluorobenzene were compared by Ermert and co-workers.
3
  
After comparison, it was concluded that the reductive elimination of the symmetrical 
diaryliodonium salts was the most efficient, with a radiochemical yields of up to 65 %.  
The unsymmetrical diaryliodonium salt reductive elimination resulted in  lower yields of 
up to 37 %.  This lower yield was attributed to the formation of [
18
F]fluorobenzene (30 
%).  Although the symmetrical diaryliodonium salts offer the highest yields, it can be 
particularly difficult to synthesize the corresponding symmetical salt of a desired 
radiotracer candidate if it is highly functionalized.   
Studies have been performated in an effort to optimize fluorination of target 
compounds via reductive elimination of unsymmetrical diaryliodonium salts.  
Specifically, Woodcraft and co-workers
8
 and Suzuki and co-workers
9
 have achieved high 
radiochemical yields of multiple fluorinated aromatic substrates under nucleophilic 
conditions (Kryptofix 222 KF, Tetrabutylammonium fluoride (TBAF)) in polar solvents 
(CH3CN, DMSO).  A key conclusion from all fluorination is that the more electron-
deficient ring is functionalized predominantly.
10
  The explanation for the observed 
regioselectivity is that negative charge builds on the attacked ring at the transition state, 
and this charge is best supported on the electron-poor ring. 
19 
 
 
Scheme 1-3 List of diaryliodonium fluorides made and studied  
Bijia Wang of the DiMagno group prepared a variety of diaryliodonium fluorides 
(Scheme 1-3).  The reductive elimination of these diaryliodonium fluorides in acetonitrile 
was investigated, and the results of the thermal decomposition studies are included in 
Table 1-2. 
Table 1-2 Observed yields of ArF from the decomposition of 1-8 
                           1 eq. TMAPF6 present No salt present 
# 
CD3CN C6D6  CD3CN C6D6  
(ArF + 4FA) (ArF + 4FA) (ArF + 4FA) (ArF + 4FA) 
1 17 ( - ) 76 ( - ) 43 ( - ) 86 ( - ) 
2 3 (2 + 1) 78 (59 + 19) 38 (30 + 8) 91 (77 + 14) 
3 3 (2 + 1) 84 (59 + 25) 60 (40 + 20) 72 (49 + 23) 
4 3 (2 + 1) 90 (76 + 14) 81 (49 + 32) 90 (78 + 12) 
5 3 (1 + 2) 67 (28 + 39) 34 (7 + 27) 70 (32 + 38) 
6 4 (3 + 1) 51 (41 + 10) 55 (40 + 15) 77 (57 + 20) 
7 33 (33 + 0) 86 (86 + 0) 68 (68 + 0) 95 (85 + 10) 
8 0   98 (93 + 5) 78 (78 + 0) 89 (89 + 0) 
20 
 
It was clear from this initial work that the use of polar solvents led to non-
productive side reactions of these compounds.  In the presence of fluoride, reduction of 
the I(III) salts to Aryl iodides was observed without generation of fluorinated arenes.  
Since fluoride is a strong donor for transition metal ions, it was suspected that 
disproportionation and subsequent redox reactions were the cause of this non-productive 
decomposition chemistry.  To suppress these side reactions, the DiMagno group 
performed the thermal decomposition reactions in non-polar solvents; this change 
resulted in drastically improved yields of fluorinated arenes.  After successfully 
optimizing solvent conditions, the effect of “spectator salts” such as 
tetramethylammonium hexafluorophosphate (TMAPF6) was investigated by Kiel 
Neumann.  He demonstrated (Table 1-1) that the presence of seemingly innocuous salts 
has a deleterious effect on the yield of fluorinated arenes isolated from the reaction.  By 
filtering off the salt prior to the decomposition reaction, yields improved.  It is 
worthwhile to note, as seen in previous studies, that fluorination of the more electron-
deficient ring occurs selectively and that the reaction rates are faster for those salts 
bearing electron withdrawing substituents.  Regioselectivity is not as high as is desired 
for some salts when the two rings are similarly electron-rich.  
 It is worth noting that diaryliodonium salt fluorination reactions can be scaled 
down for PET chemistry.  Because the DiMagno group does not currently have access to 
18
F, we have developed a MS-based assay to detect nanogram amounts of product in the 
presence of a million fold excess of potential substrate, minimizing the conditions for 
radiotracer synthesis.  This technique was sufficiently sensitive to detect and quantify 
21 
 
reproducible 500 femtograms of injected 4-fluoroanisole.  This approach is also 
potentially useful for assessing 
18
F/
19
F ratios immediately after bombardment.   
The impact of substrate and fluoride dilution was investigated because radiotracer 
synthesis is typically conducted in the fluoride concentration range of nM - µM.  If only 
the pure bis(4-methoxyphenyl)iodonium fluoride is present, dilution greatly decreases 
yield of ArF.  However, if a 20,000 fold excess of substrate (bis(4-
methoxyphenyl)iodonium trifluoroacetate) is present, yields are reproducibly up to 80 % 
even if only 5 ng of fluoride is available. 
 Once the conditions for reductive elimination of diaryliodonium fluorides were 
optimized, the goal of the research was practical application of this new methodology to 
fluorinate a clinically-relevant radiotracer candidate (Scheme 1-4).   
Scheme 1-4  Fluorination of drug candidates 
 Using our novel fluorination methodology and diaryliodonium salt precursors, 
19
F-6-Fluorodopamine was prepared by Linlin Qin, 
19
F-2-fluoroestradiol by ShriHarsha 
Uppaluri, 3-fluoro-5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]benzonitrile (F-MTEB)
11
 by 
Kiel Neumann, and 
19
F-6-fluorodihydroxyphenylalanine (F-DOPA)
12
 by Bijia Wang and 
Linlin Qin.  Two Boc protecting groups were necessary in order to suppress the reducing 
22 
 
nature of the nitrogen and convenience of cleaving the protecting group.  The yields for 
these fluorinated compounds were 90 %, 42 %, 84 %, and 85 %, respectively.  
Radiochemical yields for the F-MTEB were identical to chemical yields, fully surpassing 
previously established 
18
F-MTEB radiochemical yield benchmarks (3 – 5 %)11.  The F-
DOPA radiochemical yield was 30 % for n.c.a. methods, and is still climbing.  Both the 
F-MTEB and F-DOPA reactions are complete within 50 minutes (including separation), 
which is also optimal for radiochemical tracer synthesis.  The 
19
F-2-fluoroestradiol 
suffered in yield due to the lack of regioselectivity in the reductive elimination process.  
These initial results of fluorination of drug candidates are very promising, but it seemed 
clear that a better directing group is needed if extremely electron-rich rings are to be 
fluorinated in high chemical (or radiochemical) yield using diaryliodonium salts. 
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CHAPTER TWO 
The First I(III) Cyclophanes 
 
2.1  Regiospecific Reductive Elimination from Diaryliodonium Salts 
 Diaryliodonium salts are useful precursors for arylation of diverse carbon and 
heteroatom nucleophiles.
[1-4]
 In practice, poor regioselectivity for reductive elimination 
narrows the synthetic scope of diaryliodonium salts (Scheme 2-1). Efficient conversion is 
best obtained when two identical aryl substituents are on I(III), however, the preparation 
of symmetrical diaryliodonium salts can be problematic and uneconomical.
[11]
 For 
relatively complex aromatic molecules, the tandem synthesis and protection of the 
oxidized (I(III)) and reduced (organometallic) coupling partners necessary to prepare the 
symmetrical diaryliodonium salt is often a significant challenge, and purification of the 
functionalized product from the reductively eliminated aryl iodide can prove difficult. 
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I
X
X + I
I + X+
IO
X-
O XX
I
X- XX
I
X-
XX
X = Br, 0.1 M in chloroform, 55 °C
IO
X-
O XX
X = Br, 10 mM in DMF, 100 °C 10 h
X = Br, 10 mM in DMF, 100 °C 10 h
26.8 73.2
27.1 72.9
aryliodides
aryliodides
aryliodides
aryliodides
1 9:
:
:
X = Br, 12.5 mM in DMF, 100 °C 5 h 86.7 13.3:
X = N3, 0.25 M in Dioxane/water, 80 °C 2 h
24 65:
X = SCN, 0.25 M in Dioxane/water, 100 °C 24 h 30 : 69
X = diethyl methylmalonate,
0.25 M in DMF,  with NaH, RT
X = diethyl methylmalonate,
0.25 M in DMF,  with NaH, 0 °C
X = diethyl methylmalonate,
0.25 M in DMF,  with NaH, RT combined yield: 91%25 75:
7 93: combined yield: 86%
1 9: combined yield: 82%
I
X-
XX aryliodides
X = F, 80 mM in acetonitrile, 
85 °C 40 min
only product
O O
yield: 11%
 
Scheme 2-1  Examples of regioselectivities obtained in thermal decomposition 
reactions of unsymmetrical diaryliodonium salts.
[5-10]
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In the thermal decomposition of unsymmetrical diaryliodonium salts, the identity 
of the aryl iodide reductively eliminated is typically dictated by electronic effects; the 
electron-rich aryl iodide and the functionalized electron-poor aromatic compound are 
formed predominantly (Scheme 2-1). Selectively functionalized electron-rich aromatic 
rings are often the desired target compounds, but extremely electron-rich diaryliodonium 
salts are prone to side reactions involving redox and inner-sphere electron transfer, thus 
there is a limit to using electronic control to achieve regioselectivity.  
We sought a universal “locked” aryl substituent that would result in 
StereoElectronic Control of Unidirectional Reductive Elimination (SECURE) from 
diaryliodonium salts. Since electronic effects cannot be used exclusively to achieve this 
end, steric and/or stereoelectronic effects must be exploited to gain regiocontrol of 
reductive elimination. Here we show that the use of cyclophane-derived iodonium salts 
permits regiospecific reductive elimination (Scheme 2-2). 
27 
 
 
Scheme 2-2  Regiochemically controlled reductive elimination of an electron-rich, 
cyclophane-derived diaryliodonium salt 
The impact of steric effects upon reductive elimination in diaryliodonium salts 
has been investigated in some detail. Aryl methyl substituents ortho to the I(III) center 
offer a modest acceleration in elimination rates, so that there is a slight preference for the 
more highly substituted product to be functionalized (Scheme 2-2).
[7, 12]
 Two potential 
origins of this “ortho effect” are: 1) the more sterically demanding aromatic ring prefers 
an equatorial position syn to the nucleophile, and 2) the ortho-substituted aromatic is 
more likely to prefer a conformation in which the π-system is more likely to align with 
the incoming nucleophile.
[13-15]
 In an exception to this rule, Ochiai and coworkers have 
shown that for binaphthyl aryl iodonium salts, ortho-substitution coupled with sterically 
demanding enolate nucleophiles results in alkylation of the less hindered ring, though 
only a small number of electronically similar aryl rings were investigated.
[16]
  Selective 
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functionalization of the more electron-rich aromatic ring in an unsymmetrical 
diaryliodonium salt remains an unsolved problem.  
Our approach was to design an aryl ligand on iodine that would generate a highly 
strained reductive elimination transition state. If the mechanistic assumption of a 
concerted reductive elimination process is adopted, selective destabilization of this 
transition state requires significant steric congestion above and/or below the aromatic 
ring and little steric congestion in the plane of the ring. Thus, “strapped” or “capped” 
aromatic compounds were the initial leads for investigating SECURE methodology. 
[2.2]Paracyclophane
[17, 18]
 is a particularly attractive potential iodine(III) ligand because 
of its commercial availability, its efficient and established functionalization chemistry,
[19]
 
its severe out of plane steric congestion, and the potential to exploit the planar chiral 
ligand in stereoselective reactions;
[20]
 however, compounds in which an I(III) center is 
bonded directly to [2.2]paracyclophane have not been reported to date.  
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Scheme 2-3  Calculated TS structures and activation barriers for (2,5-
dimethylphenyl) and [2.2]paracyclophan-4-yl iodonium salts. 
 The results of an initial computational study (B3LYP/DGDZVP, ZPE 
corrected) are shown in Scheme 2-3. We selected azide transfer in diaryliodonium salts 
for our test reaction since diaryliodonium azides are known to undergo reductive 
elimination at or near room temperature,
[9, 21]
 and because the small azide nucleophile has 
a relatively modest steric demand. Ground and transition state energies were calculated 
for a highly simplified model of azide substitution, loss of HI from the HIN3Ar 
complexes of p-xylene and [2.2]paracyclophane. Inspection of Scheme 2-3 shows that 
movement from the ground state to the transition state geometries for azide substitution is 
accompanied by ipso carbon rehybridization and deflection of the HI group out of the 
plane. For the xylyl derivative the C4-C1-I angle is 161.9º. However, in the 
[2.2]paracyclophan-4-yl transition state structure the significant steric demand of the 
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second ring in the planar chiral ligand inhibits out of plane movement of the iodine atom 
(C4-C1-I angle is 167.2º). This structural difference is associated with an energetic 
penalty; the calculated free energy of activation for reductive elimination of HI from the 
p-xylene salt is 13.7 kcal/mol, while the barrier for the cyclophane derivative is 4.8 
kcal/mol higher. Armed with an “in silico” justification for the SECURE concept, we 
sought its empirical validation.   
To compare the directing effects of the electronically similar p-xylyl and 
[2.2]parcyclophan-4-yl groups experimentally, we synthesized the appropriate 
unsymmetrical diaryliodonium salts 1. 4-Bromo-[2.2]paracyclophane
[19, 22]
 was lithiated 
(t-BuLi, Et2O, -78 ºC) and transmetalated with anhydrous zinc chloride. Following 
removal of the ether solvent, the organozinc chloride reagent was treated with 2,5-
dimethyl(diacetoxyiodo)benzene in acetonitrile at -40 ºC. After isolation and ion 
exchange to the hexafluorophosphate salt, compound 1 was formed in 18% yield. 
(Though organolithium,
[23, 24]
 organoboron,
[25]
 organosilicon,
[26]
 and organotin
[27]
 
compounds have been used for diaryliodonium salt synthesis, to our knowledge this is the 
first example of the preparation of a diaryliodonium salt from an arylzinc chloride. The 
unusual reaction conditions used here were required because 4-
trialkylstannyl[2.2]paracyclophanes do not transfer the cyclophane moiety cleanly in 
transmetalation reactions.
[28]
 A likely explanation for the poor reactivity of the stannane 
is that the transition state for cyclophane transfer is highly congested and resembles that 
shown in Scheme 2-3.) 
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Scheme 2-4  Functionalization of diaryliodonium salts. (Reductively eliminated aryl 
iodides are omitted for clarity.) 
The hexafluorophosphate salt of 2-1 is particularly convenient because a wide 
range of nucleophiles may be introduced via their tetraalkylammonium or sodium salts. 
Accordingly, when compound 2-1 was treated with TBAN3 and heated at 45 ºC in 
CD3CN (0.04 M), conversion of the diaryliodonium azide was complete within a few 
hours. In support of the initial hypothesis, the azidoxylene is formed exclusively in 
excellent yield, and no azidocyclophane is observed at the detection limit of 
1
H NMR 
spectroscopy. This unidirectional elimination is also observed with thiocyanate, 
phenoxide, thiophenoxide, trifluoroethoxide, and acetate (Table 1). The observed 
32 
 
selectivity (> 99:1) corresponds to a difference in the free energies of activation (ΔΔG‡) 
of at least 2.8 kcal/mol. Thus, the validity of the computational model is confirmed.  
To provide context for the SECURE results, arene functionalization by various 
nucleophiles (X) in compound 2-2 was investigated. The regioselectivity observed during 
the reductive elimination of cyclophanyl-substituted diaryliodonium salts mirrors that of 
4-methoxyphenyl derivatives (Table 2-1). The 4-methoxyphenyl moiety is the most 
effective, commonly employed directing group in diaryliodonium chemistry
[10, 29, 30]
, 
however perfect regioselectivity for arene functionalization is not observed with this 
directing group.  For the redox active thiophenoxide and phenoxide nucleophiles, some 
loss of regiocontrol is evident and functionalized anisoles are formed.  
To test the relative directing group abilities of 4-methoxyphenyl and 
[2.2]paracyclophan-4-yl substituents, we prepared the unsymmetrical I(III) derivative 2-3 
from 4-methoxy(diacetoxyiodo)benzene (38% yield) and examined its thermal 
decomposition chemistry. More vigorous reaction conditions (80 ºC, CD3CN) were 
necessary to promote speedy carbon-heteroatom bond formation with acetate and 
thiocyanate from 2-3 in comparison to 2-1 or 2-2. As can be seen from inspection of 
Table 2-1, the directing group ability of the [2.2]paracyclophane ligand is comparable or 
slightly superior to that of the 4-methoxyphenyl substituent on I(III).  
The 2-thienyl substituent has been reported to deliver high regioselectivities for 
the radiofluorination of various electron-rich arenes,
[31]
 We synthesized 4 to examine the 
relative directing group abilities of the 2-thienyl and 4-methoxyphenyl substituents under 
stoichiometric conditions. Inspection of the data in Table 2-1 indicates that, for the 
nucleophiles examined here, the 2-thienyl moiety’s directing group ability is roughly 
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comparable to the 4-methoxyphenyl and [2.2]paracyclophane ligands on I(III). In all 
cases significant amounts of the 4-iodoanisole are generated during the thermal 
decomposition reactions of 2-4, even when 2-functionalized thiophenes are not observed. 
These data support Carroll’s assessment[32] and the original observations by Yamada and 
Okawara
[33]
 that the directing group ability of the 2-thienyl and 4-methoxyphenyl 
substituents are similar. 
Table 2-1  Yields
a
 of reductive elimination products from the I(III) salts shown in 
Scheme 2-4. 
X 2-1 2-2 2-3 2-4 
 2-1a 2-1b 2-2a 2-2b 2-3a 2-3b 2-4a 2-4b 
N3 99< 0 99< 0 86 14 66 0
b
 
OAc 85 0 99< 0 68 31 18 0
b
 
OPh 87 0 96 4 51 40 69 23 
OCH2CF3 82 0 80 0 19 39 17 43 
SCN 99< 0 99< 0 81 18 43 0
b
 
SPh 98 0 95 5 43 52 30 40 
a
All yields were determined by 
1
H NMR spectroscopy and confirmed by GC-MS. 
b
Decomposition of the functionalized thiophene was observed. 
Though the data in Table 1 are limited, it appears that for oxygen or sulphur 
nucleophiles the directing group ability of the cyclophane ligand diminishes as 
nucleophile basicity and the driving force for functionalizing the more electron-poor ring 
increase. Such a trend is consistent with Hammond’s postulate and a concerted, reductive 
elimination mechanism in which less steric strain is developed at the cyclophane ipso 
carbon atom as the reaction becomes more exergonic. 
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The kinetics of aryl azide formation from N3 salts of 2-1, 2-2 and 2-3 were 
investigated to probe the relative steric and electronic contributions to the observed 
regioselectivity.  The observed rate constants for xylyl azide formation (CD3CN, 45 ºC) 
were 4.2 x 10
-4
 s
-1
, 5.5 x 10
-5
 s
-1
, and 3.3 x 10
-6
 s
-1
, corresponding to free energies of 
activation of 21.7, 22.9, and 24.6 kcal/mol for the reactions of 2-1, 2-2 and 2-3, 
respectively. The fact that the rate constant for formation of azidoxylene is greater for 1 
than 2-2 indicates that 4-iodo-[2.2]paracyclophane is a significantly better leaving group 
than 4-iodoanisole. Since leaving group ability is correlated with the electron density on 
iodine in the aryl iodide being reductively eliminated, these kinetic data show 
experimentally that the [2.2]paracyclophane ligand is a significantly more electron-poor 
aryl substituent than 4-methoxyphenyl and that steric destabilization of the transition 
state is responsible for the enhanced directing group ability of the [2.2]paracyclophane 
ligand. 
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Scheme 2-5  Synthesis of 2-5. (a. 1. t-BuLi, Et2O, -78 °C, 2. B(OMe)3, 3. H2O2, NaOH, 
H2O; b. K2CO3, CH3I, CH3CN, 80 °C; c. NBS, CH2Cl2; d. 1. t-BuLi, Et2O, -78 °C, 2. 
ZnCl2; e. 1. 4-MeOC6H4I(OAc)2, CH3CN, -40 °C, f. NaPF6, H2O.)  
 
These initial results validated the SECURE concept, but perfect regiochemical 
control was still not available for functionalizing very electron-rich rings. To address this 
issue we prepared compound 2-5, which features an electron donating methoxy 
substituent para to the I(III) center (Scheme 2-5). The methoxy substituent enhances the 
solubility of the cyclophane organozinc chloride reagent, leading to improved yield in the 
I(III) transfer reaction.  
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Scheme 2-6  Anisole functionalization by thermal decomposition of 2-5 in CD3CN  
We were gratified to find that 2-5 provides excellent regiochemical control for 
arene functionalization across the range of nucleophiles investigated here. Only anisole 
substitution was observed after the thermal decomposition of the azide, acetate, 
phenoxide, thiocyanate, and thiophenoxide salts (Scheme 2-6). However, a mixture of 
cyclophane- (30%) and anisole-substituted (60%) products was obtained from the 
reductive elimination of the 2,2,2-trifluoroethoxide salt of 2-5. The reason for the 
breakdown in regioselectivity is clear from the product analysis, which shows roughly 
equal amounts of 3- and 4-(2,2,2-trifluoroethoxy)anisole, as well as roughly equal 
amounts of the two CF3CH2O-substituted cyclophane regioisomers. This lack of 
selectivity and distribution of regioisomers is consistent with a change in mechanism to 
one involving benzyne intermediates. For this basic nucleophile, the strategy of raising 
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the transition state energy for reductive elimination of the aryl iodide enables the benzyne 
reaction manifold to be competitive. 
In summary, computational and experimental data show that an increase in steric 
demand above the plane of the aromatic ring destabilizes a reductive elimination 
transition state. This effect is sufficiently large to provide stereoelectronic control of 
unidirectional reductive elimination (SECURE); a number of examples are provided to 
show that the intrinsic electronic bias in reductive elimination reactions of I(III) 
compounds can be overcome. Significantly, even 4-methoxyphenyl groups can be 
functionalized regiospecifically. Moreover, since the approach is a general one, it is 
anticipated that SECURE will be useful for controlling reductive elimination from a 
variety of high valent main group and transition metal ions. 
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 CHAPTER THREE 
Regiospecific Fluorination of Electron-Rich Arenes 
 
3.1  A solution to observed benzyne chemistry 
As stated in 2.1, a mixture of products (cyclophane- (30 %) and anisole-
substituted (60 %)) were obtained from reductive elimination of the 2,2,2-
trifluoroethoxide salt.  This suspected benzyne chemistry was also observed when 
fluorine was used as the nucleophile.  The proposed mechanism that resulted in formation 
of these products is shown in Scheme 3-1. 
 
Scheme 3-1  Observed products and proposed mechanistic benzyne pathway 
We suspected that a cyclophane substituent ortho to the I(III) center would shut 
down benzyne chemistry on the cyclophane and restore regiospecificity for fluorination.  
Toward this end, we developed a synthesis of compound 3-1 shown in Scheme 3-2. 
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Scheme 3-2  Synthesis of 3-1 
Our original approach to obtaining 3-1 was through ortho-lithiation of 4-
methoxy[2.2]paracyclophane and subsequent transmetalation with zinc chloride.  Direct 
ortho-lithiation of methoxy cyclophane was not successful, even with t-BuLi or with n-
BuLi / tetramethylethyldiamine (TMEDA) mixtures.  We suspect that the steric 
congestion of the cyclophane ring system makes ortho-activation difficult.  Thus, we 
installed a better ortho directing group (carbamate) and planned a more indirect synthesis 
(Scheme 3-2).  This synthesis relied heavily on the work of Hopf
1
, Lectka
2
, and 
Snieckus
3
 who showed that efficient lithiation was possible with the carbamated directing 
group.  By synthesizing O-(4-[2.2]paracyclophanyl) diethylcarbamate, we were able to 
obtain the corresponding 4-methoxy-5-iodo[2.2]paracyclophane in 73% yield over four 
steps.  Following our previous synthetic strategy for introducing the iodoanisole moiety 
into 2-3, 2-4, and 2-5, we were able to obtain 3-1 in 13% yield.  
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Scheme 3-3  Reductive elimination from the iodonium fluoride of 3-1. 
Reductive elimination reactions with the iodonium fluoride of 3-1 were studied 
(Scheme 3-3).  The results demonstrated that by blocking the ortho position with a 
methoxy group, benzyne chemistry was completely shut down on the cyclophane ring.  
Using NMR and GC analysis, the 4-fluoroanisole was the major product, and was 
obtained in 55 % yield.  To our surprise, evidence for benzyne chemistry on the anisole 
ring was almost absent; less than a 1% yield of 3-fluoroanisole was present when the 
thermal decomposition reaction was conducted at 80 °C (Scheme 3-3). 
3.2  Conclusion 
 We have shown that the choice of a judiciously substituted cyclophane substituent 
on I(III) can provide perfect regioselectivity for reductive elimination of iodocyclophanes 
and fluorination of electron-rich arenes.  This work constitutes the first example of 
regiospecific fluorination of electron-rich aromatic rings using diaryliodonium fluorides.  
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We believe this discovery paves the way for the synthesis of highly elaborated 
radiotracers from Ar2IF salts. 
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Experimental Procedures 
 
Bis(acetyloxy)-(4-methoxyphenyl)-λ3 –iodane; (1-(diacetoxyiodo)-4-
methoxybenzene) 
 
I OAcAcO
OCH3  
4-Iodoanisole (2.34 g, 10 mmol) was dissolved in 90 mL of glacial acetic acid and 
the stirred solution was warmed to 40 °C. Sodium perborate tetrahydrate (13.6 g, 110 
mmol) was added in portions over the course of one hour. After the addition was 
complete, the temperature of the reaction mixture was maintained at 40 °C for 8 h before 
it was allowed to cool to room temperature. Half of the acetic acid (~ 45 mL) was 
removed by distillation at reduced pressure. The remaining solution was treated with 100 
mL of deionized water and the aqueous layer was extracted (3 × 40 mL) with 
dichloromethane. The combined organic fractions were dried over sodium sulfate, and 
the solvent was removed by rotary evaporation to give 2.25 g (64%) of 1-
(diacetoxyiodo)-4-methoxybenzene, 1. This compound was dried in vacuo and used 
without further purification. 
1
H NMR (CD3CN, 400 MHz, 25 °C): δ 8.055 (d, J = 9.1 Hz, 
2H, H2/H6), 7.053 (d, J = 9.1 Hz, 2H, H3/H5), 3.861 (s, 3H, OMe), 1.905 (s, 6H, 
(OCOCH3)2); 
13
C NMR (CD3CN, 100 MHz, 25 °C) δ 177.73 (CO), 163.73 (C4), 138.75 
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(C2/C6), 118.00, (C3/C5), 111.97 (C1), 56.85 (OMe), 20.76 ((OCOCH3)2); HRMS: 
(HRFAB) calcd. for C14H13NO4I [M – 2OAc+3-NBA]
+
 385.9889 found 385.9885. (lit. 
2,3
 
13
C NMR (CDCl3, 50 MHz, 20 °C) δ 162.0 (C4), 137.0 (C2/C6), 116.5 (C3/C5), 111.4 
(C1).); 
13
C NMR (CDCl3, 75 MHz, 25 °C) δ 176.31 (CO), 111.64 (C1), 20.36 
((OCOCH3)2).) 
 
4-Bromo-[2.2]paracyclophane 
 
Br
 
N-Bromosuccinimide (890.1 mg, 5.0 mmol) and trifluoroacetic acid (570 mg, 
0.385 mL, 5.0 mmol) were dissolved in 40 mL of dichloromethane and added to a 
CH2Cl2 solution (80 mL) of [2.2]paracyclophane (1.0297 g, 4.9 mmol). The resulting 
mixture was covered from light and stirred for 4 hours at room temperature. The solution 
was transferred to a separatory funnel and washed (3 x 50 mL) with 2 M aqueous sodium 
bicarbonate solution followed by a single deionized water wash. The organic layer was 
separated, dried over Na2SO4, and the solvent was evaporated to give a nearly colorless 
solid (1.061 g, 75%) that was sufficiently pure to carry forward in the synthesis. 
1
H NMR 
(CDCl3, 400 MHz, 25 °C): δ 7.18 (dd, J = 7.8, 1.9 Hz, 1 H), 6.45-6.61 (m, 6 H), 3.45-
3.52 (m, 1 H), 2.80-3.26 (m, 7 H); 
13
C NMR (CDCl3, 100 MHz, 25 °C) δ 141.61, 139.33, 
47 
 
139.11, 137.25, 135.05, 133.31, 133.02, 132.91, 132.25, 131.46, 128.69, 126.97, 35.85, 
35.48, 34.82, 33.47. 
Cram, D. J.; Day, A. C. J. Am. Chem. Soc. 1966, 31, 1227-32. 
 
4-Hydroxy[2.2]paracyclophane  
 
HO
 
In a 50 mL Schlenk tube under nitrogen, a stirred, cold (-78 ºC) solution of 4-
bromo[2.2]paracyclophane (4.0 mmol, 1.14 g) in 50 mL of anhydrous diethyl ether was 
treated with t-BuLi (1.7 M in pentane, 2.5 equiv., added dropwise). The resulting mixture 
was stirred at -78 ºC for 20 minutes and held subsequently at 0 ºC for 20 min. To this 
heterogeneous yellow mixture trimethyl borate (831.29 mg, 8.0 mmol) was added 
dropwise and the mixture was stirred for 1 hour at room temperature. During this period 
the solution became homogeneous and dark yellow. Aqueous NaOH (0.5 M, 2 mL) and 
H2O2 (30%, 1.5 mL) were added. There was a slight exotherm and gas was evolved. The 
resulting mixture was allowed to stir overnight at room temperature. Additional aqueous 
NaOH solution (0.5 M, 5 mL) was added and the pH of the solution was adjusted to 
neutral using saturated sodium bicarbonate solution and 1 M HCl. The mixture was 
extracted (3 x 20 mL) with diethyl ether. The combined ether extracts were washed with 
0.5 M sodium bisulfite, separated, and dried over Na2SO4. Removal of the solvent by 
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rotary evaporation gave a light brown solid (844.1 mg, 94.1%).
 1
H NMR (CDCl3, 400 
MHz, 25 °C): δ 7.01 (dd, J = 7.8, 1.9 Hz, 1 H), 6.56 (dd, J = 7.8, 1.9 Hz, 1 H), 6.46 (dd, J 
= 7.8, 1.9 Hz, 1 H), 6.38-6.42 (m, 2 H), 6.27 (dd, J = 7.7, 1.6 Hz, 1 H), 5.55 (d, J = 1.6 
Hz, 1 H), 3.29-3.39 (m, 1 H), 2.87-3.16 (m, 6 H), 2.62-2.73 (m, 1 H). 
13
C NMR (CDCl3, 
100 MHz, 25 °C): δ 153.7, 142.0, 139.6, 138.8, 135.5, 133.0, 132.8, 131.9, 127.9, 125.4, 
125.0, 122.6, 35.3, 34.8, 33.8, 31.1. 
Krohn, K.; Rieger, H.; Hopf, H.; Barrett, D.; Jones, P. G.; Döring, D.  Chem. Ber. 1990, 
123 1729. 
 
4-Methoxy[2.2]paracyclophane 
MeO
 
In a 100 mL glass tube sealed with a Teflon screw cap closure, potassium 
carbonate (1.66 g, 12 mmol) and 4-hydroxy[2.2]paracyclophane (869.6 mg, 3.87 mmol) 
were heated to 80 ºC in 60 mL of acetonitrile for 30 minutes. Iodomethane (1.7 g, 12 
mmol) was added to the mixture, the storage tube was sealed, and the stirred solution was 
heated at 80 ºC for 3 days. The solvent was removed by rotary evaporation and the 
remaining solid was treated with ethyl acetate and water and transferred to a separatory 
funnel. The aqueous layer was neutralized with 0.1 M HCl solution, the mixture was 
shaken, and the organic layer was separated and dried over Na2SO4. Rotary evaporation 
of solvent yielded a nearly colorless solid. The somewhat insoluble material was 
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dissolved in hot hexanes and purified via column chromatography (silica gel, hexanes, Rf 
= 0.28) to afford a colorless solid (602.4 mg, 65.4%). 
 1
H NMR (CDCl3, 400 MHz, 25 
°C): δ 6.76 (dd, J = 7.8, 1.8 Hz, 1 H), 6.38 – 6.55 (m, 4 H), 6.28 (dd, J = 7.5, 1.4 Hz, 1 
H), 5.67 (d, J = 1.3,  1 H), 3.71 (s, 3 H), 3.42 – 3.48 (m, 1 H), 2.99 – 3.13 (m, 6 H), 2.59 
– 2.66 (m, 1 H). 13C NMR (CDCl3, 100 MHz, 25 °C): δ 157.6, 142.1, 140.3, 138.8, 135.0, 
133.7, 133.1, 131.5, 128.4, 127.5, 124.4, 116.7, 54.3, 35.5, 35.4, 34.1, 31.7. 
Cram, D. J.; Day, A. C. J. Org. Chem. 1966, 31, 1227-32. 
 
O-(4-[2.2]paracyclophanyl) diethylcarbamate 
 
 
In a 250 mL Schlenk flask, a solution of 4-hydroxy[2.2]paracyclophane (2.88 
mmol, 644.9 mg) in 50 mL of anhydrous toluene was treated with 4-
(dimethylamino)pyridine (DMAP) (5.76 mmol, 703.7 mg) and diethylcarbamoyl chloride 
(5.76 mmol, 0.73 mL).  The resulting mixture was stirred at reflux for 7 hours, while the 
progress of the reaction was monitored by TLC (silica gel, dichloromethane).  The 
reaction was cooled to room temperature, hydrolyzed with 50 mL of deionized water, and 
extracted (3 x 35 mL) with dichloromethane.  The combined organic extracts were dried 
over Na2SO4.  The solvent was removed by rotary evaporation, and the raw product was 
purified by column chromatography (silica gel, dichloromethane) to afford a white 
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crystalline  solid (698.9 mg, 75%).  
1
H NMR (CDCl3, 400 MHz, 25 °C): δ 6.85 (dd, J = 
7.8, 1.3 Hz, 1 H), 6.41-6.57 (m, 5 H), 6.12 (d, J = 1.3 Hz, 1 H), 3.66 (q, br, 2 H), 3.40 (q, 
br, 2 H), 3.25 (m, 1 H), 3.05, (m, 6 H), 2.73 (m, 1 H), 1.42 (t, br, 3 H), 1.22 (t, br, 3 H) 
13
C NMR (CDCl3, 100 MHz, 25 °C): δ 153.7, 149.5, 141.3, 139.5, 139.3, 135.1, 133.4, 
133.0, 132.2, 131.1, 129.5, 129.4, 128.6, 42.2, 41.9, 35.3, 34.9, 34.6, 31.7, 14.5, 13.5. 
Barrett, D.G.; Hopf, H.  Liebigs. Ann. 1995, 449-451. 
 
O-[4-(5-iodo-[2.2]paracyclophanyl)] diethylcarbamate 
 
 
In a 250 mL Schlenk tube, a solution of O-(4-[2.2]paracyclophanyl) 
diethylcarbamate (2.16 mmol, 698.9 mg) in 55 mL of anhydrous tetrahydrofuran (THF) 
was treated with tetramethylethyldiamine (TMEDA) (2.6 mmol, 0.39 mL) and cooled to -
78 °C.  The resulting mixture was treated with sec-butyllithium (1.4 M in cyclohexane, 
2.92 mmol, drop wise) and stirred at -78 °C for 2 h.  The reaction mixture became clear 
yellow.  After 2 h, a solution of diiodoethane (6.48 mmol, 1.83 g) in anhydrous THF was 
added drop wise to the reaction mixture.  The resulting mixture was then allowed to 
slowly warm to room temperature overnight.  After 15 h, the solution had turned dark 
purple.  The THF was removed in vacuo and the residue dissolved in 55 mL of Et2O and 
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55 mL of aqueous 5% sodium thiosulfate.  The organic layer was washed again with an 
additional 55 mL of aqueous 5% sodium thiosulfate.  The aqueous phase was extracted 
with Et2O (3 x 20 mL).  The organic layers were combined, washed with 20 mL 1 M 
HCl, and dried over Na2SO4.  The solvent was evaporated to afford an off-white 
crystalline solid (949.2 mg, 98%).  
1
H NMR (CDCl3, 400 MHz, 25 °C): δ 7.14 (d, J = 8.0 
Hz, 1 H), 6.67 (d, J = 7.3 Hz, 1 H), 6.52 – 6.60 (m, 3 H), 6.45 (d, J = 7.8 Hz, 1 H), 3.77 – 
3.85 (m, 1 H), 3.52 – 3.61 (m, 1 H), 3.35 – 3.47 (m, 3H), 2.97 – 3.21 (m, 6 H), 2.78 – 
2.86 (m, 1 H), 1.50 (t, J = 7.1 Hz, 3 H), 1.23 (t, J = 7.1 Hz, 3 H). 
13
C NMR (CDCl3, 100 
MHz, 25 °C): δ 152.6, 149.1, 145.3, 139.1, 138.6, 134.4, 133.3, 132.9, 132.9, 130.6, 
128.9, 128.6, 103.6, 42.4, 42.1, 39.2, 34.5, 33.0, 31.8, 14.7, 13.4. 
Wack, H.; France, S.; Hafez, A.; Drury, W.; Weatherwax, A.; Lectka, T. J. Org. Chem. 
2004, 69, 4531. 
4-Hydroxy-5-iodo-[2.2]paracyclophane 
 
In a 50 mL round bottom flask, O-[4-(5-iodo-[2.2]paracyclophanyl)] 
diethylcarbamate (930.8 mg, 2.07 mmol) and potassium hydroxide (2.90 g, 51.75 mmol) 
were suspended in 15 mL of ethylene glycol.  Hydrazine (331.7 mg, 10.35 mmol) was  
added and the mixture was heated at reflux for 2 h.  During the reflux period,  the mixture 
became homogenous.  The solution was cooled to room temperature, transferred to a 
separatory funnel, acidified to pH 1 with 1 M HCl, and diluted with deionized water.  The 
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aqueous phase was extracted with Et2O (4 x 40 mL).  The organic layers were combined, 
dried over Na2SO4, and solvent was removed in vacuo to afford an off-white solid (550.2 
mg, 78%).  
1
H NMR (CDCl3, 400 MHz, 25 °C): δ 7.04 (dd, J = 7.8, 1.5 Hz, 1 H), 6.78 
(dd, J = 7.8, 1.5 Hz, 1 H), 6.47 – 6.57 (m, 3 H), 6.27 (d, J = 7.6 Hz, 1H), 5.12 (s, 1 H), 
3.38 – 3.44 (m, 1 H), 3.25 – 3.33 (m, 1 H), 2.96 – 3.15 (m, 5 H), 2.69 – 2.76 (m, 1 H).  
13
C NMR (CDCl3, 100 MHz, 25 °C): δ 152.3, 144.5, 139.7, 137.7, 134.9, 133.1, 133.0, 
128.1, 127.3, 126.2, 125.6, 99.5, 39.3, 34.0, 32.9, 31.5. 
Wack, H.; France, S.; Hafez, A.; Drury, W.; Weatherwax, A.; Lectka, T. J. Org. Chem. 
2004, 69, 4531. 
 
4-Methoxy-5-iodo-[2.2]paracyclophane 
 
In a 100 mL glass tube sealed with a Teflon screw cap closure, potassium 
carbonate (992.3 mg, 7.18 mmol) and 4-hydroxy-5-iodo[2.2]paracyclophane (548.3 mg, 
1.56 mmol) were heated to 70 ºC in 15 mL of acetone for 30 minutes. Iodomethane 
(553.6 mg, 3.90 mmol) was added to the mixture, the tube was sealed, and the stirred 
solution was heated at 70 ºC for 1 day.  The mixture was transferred to a round bottom 
flask, the solvent was removed by rotary evaporation and the remaining solid was treated 
with 15 mL of deionized water and 15 mL of dichloromethane, and transferred to a 
separatory funnel. The aqueous layer was extracted with dichloromethane (3 x 30 mL). 
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The organic layers were combined, dried over Na2SO4, and the solvent was removed in 
vacuo to yield a nearly colorless oil. This somewhat insoluble material was dissolved in 
hot hexanes, loaded onto a silica gel column, and eluted with 10% EtOAc/hexanes) to 
afford an almost colorless product (416.7 mg, 73%) 
 1
H NMR (CDCl3, 400 MHz, 25 °C): 
δ 7.09 (d, J = 7.9 Hz, 1 H), 6.70 (d, J = 7.9 Hz, 1 H), 6.53 (d, J = 7.7 Hz, 1 H), 6.52 (s, 2 
H), 6.35 (d, J = 7.7 Hz, 1 H), 3.64 (s, 3 H), 3.38 – 3.43 (m, 1 H), 3.26 – 3.33 (m, 1 H), 
3.08 – 3.19 (m, 2 H), 2.92 – 3.03 (m, 3 H), 2.74 – 2.81 (m, 1 H).  13C NMR (CDCl3, 100 
MHz, 25 °C): δ 157.7, 145.6, 139.4, 138.4, 135.2, 132.8, 132.7, 131.8, 129.4, 128.9, 
128.7, 103.5, 60.9, 39.2, 34.5, 33.0, 31.2. 
Wack, H.; France, S.; Hafez, A.; Drury, W.; Weatherwax, A.; Lectka, T. J. Org. Chem. 
2004, 69, 4531. 
 
4-Methoxy-7-iodo[2.2]paracyclophane 
 
MeO I
 
In a 100 mL round bottom flask, a solution of 4-methoxy[2.2]paracyclophane (0.8 
mmol, 192.3 mg) in CH2Cl2 (25 mL) of CH2Cl2 was treated with a solution of N-
iodosuccinimide (0.648 mmol, 145.2 mg) and trifluoroacetic acid (0.648 mmol, 75.3 mg) 
in 25 mL of dichloromethane. The resulting mixture was stirred for 5 minutes and the 
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dark purple color of iodine developed. The solution was transferred to a separatory funnel 
and washed (3 x 50 mL) with 2 M aqueous sodium bicarbonate solution followed by a 
single deionized water wash. The organic layer was separated, dried over Na2SO4, and 
the solvent was evaporated to give an off-white solid (295.0 mg, 99%).  
 1
H NMR 
(CDCl3, 400 MHz, 25 °C): δ 7.13 (dd, J = 7.9, 1.8 Hz, 1 H), 6.75 (dd, J = 7.9, 1.8 Hz, 1 
H), 6.71 (s, 1 H), 6.46 (dd, J = 7.9, 1.8, 1 H), 6.40 (dd, J = 7.8, 1.8 Hz, 1 H), 5.69 (s, 1 H), 
3.68 (s, 3 H), 2.82-3.37 (m, 7 H), 2.43-2.53 (m, 1H). 
13
C NMR (CDCl3, 100 MHz, 25 
°C): δ 157.9, 144.7, 143.9, 139.9, 138.5, 132.9, 131.5, 129.9, 129.6, 128.9, 117.7, 91.9, 
54.3, 39.3, 33.6, 33.2, 31.1. 
 
4-Methoxy-7-bromo[2.2]paracyclophane 
 
MeO Br
 
N-Bromosuccinimide (279.4 mg, 1.57 mmol) and trifluoroacetic acid (179.0 mg, 
0.12 mL, 1.57 mmol) were dissolved in 15 mL of CH2Cl2 and added to a solution of 4-
methoxy[2.2]paracyclophane (349.7 g, 1.47 mmol) in 30 mL CH2Cl2. The resulting 
mixture was covered from light and stirred for 30 minutes at room temperature. The 
solution was transferred to a separatory funnel and washed (3 x 50 mL) with 2 M aqueous 
sodium bicarbonate solution followed by a single deionized water wash. The organic 
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layer was separated, dried over Na2SO4, and the solvent was evaporated to give light 
brown solid (400.6 mg, 86%). 
1
H NMR (CDCl3, 400 MHz, 25 °C): δ 7.10 (dd, J = 7.8, 
1.8 Hz, 1 H), 6.76 (dd, J = 7.9, 1.9 Hz, 1 H), 6.41 - 6.46 (m, 3 H), 5.69 (s, 1 H), 3.71 (s, 3 
H), 3.34 - 3.45 (m, 2 H), 3.18 - 3.25 (m, 1 H), 2.98 – 3.10 (m, 3 H), 2.71 – 2.78 (m, 1 H), 
2.46 – 2.54 (m, 1 H); 13C NMR (CDCl3, 100 MHz, 25 °C) δ 157.15, 140.81, 139.95, 
138.76, 138.65, 133.19, 133.16, 131.83, 130.00, 129.19, 118.54, 117.26, 54.69, 35.89, 
33.82, 33.51, 31.29. 
Rozenberg, V.; Zhuravsky, R.; Sergeeva, E. Chirality 2006, 18, 95-102. 
 
([2.2]Paracyclophan-4-yl)(2’,5’-dimethylphenyl)iodonium hexafluorophosphate, 2-1 
 
In a 50 mL Schlenk tube under nitrogen, a stirred solution of 4-bromocyclophane 
(1 mmol, 282 mg) in 10 mL of anhydrous diethyl ether was cooled to -78 ºC. A solution 
of t-BuLi (1.7 M in pentane, 2.3 equiv.) was added dropwise and the resulting mixture 
was stirred at -78 ºC for 20 minutes and then warmed to 0 ºC and allowed to stir for an 
additional 20 min. The reaction mixture was cooled again to -78 ºC before a solution of 
zinc chloride (200 mg, 1.5 mmol) in ether (10 mL) was added dropwise by cannula. After 
the addition, the reaction mixture was allowed to warm to room temperature over the 
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course of one hour before the solvents were removed in vacuo. The remaining solid was 
dissolved in anhydrous CH3CN and the solution was cooled to -40 ºC and added 
dropwise to precooled (-40 ºC) suspension of bis(acetyloxy)-(2,5-dimethylphenyl)-λ3–
iodane (350 mg, 1 mmol) in 10 mL of acetonitrile. The mixture was allowed to warm to 
room temperature over 30 minutes before the solvent was removed in vacuo. The 
resulting solid was washed with hexanes and then dissolved in aqueous acetonitrile. 
Addition of an aqueous NaPF6 solution precipitated the product, which was extracted 
from the aqueous mixture with CH2Cl2. The organic layer was evaporated, dissolved in a 
minimal amount of CH2Cl2, precipitated with hexanes, filtered and dried in vacuo to yield 
1 (105 mg, 18 % yield).
 1
H NMR (CD3CN, 400 MHz, 25 °C): δ 7.93 (s, 1H), 7.41 (s, 2H), 
7.29 (d, J = 1.3 Hz, 1H), 6.84 (dd, J1 = 7.8 Hz, J2 = 1.3 Hz, 1H), 6.78 (d, J = 7.8 Hz, 1H), 
6.66 (s, 2H), 6.53 (d, J = 7.9 Hz, 1H), 6.51 (d, J = 7.9 Hz, 1H), 3.04-3.41 (m, 8H), 2.50 
(s, 3H), 2.33 (s, 3H); 
13
C NMR (CD3CN, 100 MHz, 25 °C) δ 146.5, 143.6, 141.9, 141.1, 
140.2, 139.9, 139.5, 138.2, 137.7, 135.6, 134.7, 134.5, 134.1, 133.9, 133.1, 132.5, 120.6, 
118.8, 100.8, 38.9, 35.8, 35.5, 35.4, 25.3, 20.6; HRMS: (HRFAB) calcd. for C24H24I [M]
+
 
439.0923, found 439.0907.  
 
([2.2]Paracyclophan-4-yl)(4’-methoxyphenyl)iodonium hexafluorophosphate, 2-3 
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In a 50 mL Schlenk tube under nitrogen, a stirred solution of bromocyclophane (1 
mmol, 282 mg) in 10 mL of anhydrous diethyl ether was cooled to -78 ºC. A solution of 
t-BuLi (1.7 M in pentane, 2.3 equiv.) was added dropwise and the resulting mixture was 
stirred at -78 ºC for 20 minutes and then warmed to 0 ºC and allowed to stir for an 
additional 20 min. The reaction mixture was cooled again to -78 ºC before a solution of 
zinc chloride (200 mg, 1.5 mmol) in ether (10 mL) was added dropwise by cannula. After 
the addition, the reaction mixture was allowed to warm to room temperature over the 
course of one hour before the solvents were removed in vacuo. The remaining solid was 
dissolved in anhydrous CH3CN and the solution was cooled to -40 ºC and added 
dropwise to precooled (-40 ºC) suspension of bis(acetyloxy)-(4-methoxyphenyl)-λ3–
iodane (352 mg, 1 mmol) in 10 mL of acetonitrile. The mixture was allowed to warm to 
room temperature over 30 minutes before the solvent was removed in vacuo. The 
resulting solid was washed with hexanes and then dissolved in aqueous acetonitrile. 
Addition of an aqueous NaPF6 solution precipitated the product, which was extracted 
from the aqueous mixture with CH2Cl2. The organic layer was evaporated, dissolved in a 
minimal amount of CH2Cl2, precipitated with hexanes, filtered and dried in vacuo to yield 
2 (225 mg, 38.4 % yield). 
1
H NMR (CD3CN, 400 MHz, 25 °C): δ 8.00 (d, J = 9.1 Hz, 
2H), 7.27 (s, 1H), 7.08 (d, J = 9.1 Hz, 2H), 6.83 (d, J = 7.7 Hz, 1H), 6.76 (d, J = 7.7 Hz, 
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1H), 6.65 (s (broad), 2H), 6.38 (d, J = 7.9 Hz, 1H), 6.31 (d, J = 7.9 Hz, 1H), 3.84 (s, 3H), 
3.04-3.35 (m, 8H); 
13
C NMR (CD3CN, 100 MHz, 25 °C) δ 164.1, 143.2, 140.9, 139.8, 
139.4, 139.2, 138.8, 137.6, 134.3, 134.2, 133.7, 132.4, 120.9, 119.4, 100.8, 56.7, 38.4, 
35.6, 35.4, 35.3; HRMS: (HRFAB) calcd. for C23H22OI [M]
+
 441.07098, found 441.0712. 
 
(7-Methoxy[2.2]paracyclophanyl)(4’-methoxyphenyl)iodonium 
hexafluorophosphate, 2-5 
 
In a 100 mL Schlenk tube, 4-methoxy-7-bromo[2.2]paracyclophane (1.26 mmol, 
400.6 mg) was dissolved in 25 mL of distilled ether and cooled to -78 °C. To the cooled 
solution, 1.7M t-butyl lithium (3.16 mmol, 1.85 mL) was added dropwise and the stirred 
solution was held at -78 °C for 1 hour.  A solution of anhydrous zinc chloride (1.51 
mmol, 206.1 mg) in 10 mL of diethyl ether was added dropwise to the cooled solution. 
The mixture was allowed to warm to room temperature, and the solvent was removed 
under reduced pressure. The residual solid (organozinc chloride reagent and lithium salts) 
was taken up in anhydrous acetonitrile and cooled to -40 °C before a solution of 4-
methoxyphenyl iodonium diacetate (1.89 mmol, 665.5 mg) in acetonitrile (10 mL) was 
added in a dropwise fashion. After 1 hour at -40 °C, the mixture was warmed to room 
temperature and the solvent was removed under reduced pressure. Deionized water and 
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sodium hexafluorophosphate (410 mg) were added, followed by 50 mL of 
dichloromethane. The mixture was transferred to a separatory funnel and the organic 
phase was separated. The solvent was removed by rotary evaporation and the remaining 
solid was dissolved in 5 mL of dichloromethane and dripped into 150 mL hexanes. The 
precipitate was aged for one hour, collected by gravity filtration, and dried in vacuo to 
yield a colorless salt (55.6 %, 431.7 mg).
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1
H NMR (CD3CN, 400 MHz, 25 °C): δ 8.01 (d, J = 9.2 Hz, 2H, H2’, H6’), 7.25 (s, 1H, 
H8), 7.07 (d, J = 9.2 Hz, 2H, H3’, H5’), 6.81 (dd, J = 7.8, 1.8 Hz, 1H, H15), 6.62 (dd, J = 
7.9, 1.9 Hz, 1H, H16), 6.29 (dd, J = 7.9, 1.6 Hz, 1H, H13), 6.12 (dd, J = 8.0, 2.0 Hz, 1H, 
H12), 6.02 (s, 1H, H5), 3.83 (s, 3H, Mea), 3.74 (s, 3H, Meb), 3.31 (ddd, J = 11.6, 9.8, 1.7 
Hz, 1H, H2a), 3.26 (dd, J = 8.4, 5.7 Hz, 1H, H9b), 3.23 (dd, J = 13.9, 4.3 Hz, 1H, H9a), 
3.18 (dd, J = 12.9, 4.1 Hz, 1H, H10b), 3.15 (dd, J = 8.3, 3.0 Hz, 1H, H10a), 3.05 (ddd, J = 
12.8, 9.9, 6.4 Hz, 1H, H1a), 3.02 (ddd, J = 12.8, 9.9, 6.4 Hz, 1H, H1b), 2.68 (ddd, J = 
13.1, 10.5, 6.4 Hz, 1H, H2b). 
13
C NMR (CD3CN, 400 MHz, 25 °C): δ 163.3 (C4), 161.6 
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(C4’), 146.4 (C6), 140.5 (C8), 139.9 (C11), 137.9 (C14), 137.4 (C2’, C6’), 133.2 (C13), 
132.4 (C3), 131.4 (C12), 131.3 (C16), 128.8 (C15), 119.8 (C5), 118.2 (C3’, C5’), 107.4 
(C7), 101.1 (C1’), 55.8 (Mea), 54.9 (Meb), 37.2 (C9), 34.5 (C10), 32.9 (C1), 30.7 (C2). 
19
F NMR (CD3CN, 400 MHz, 25 °C): δ -72.7 (d, J = 706.7 Hz, 6F). HRMS: (HRFAB) 
calcd. for C24H24IO2 [M]
+
 471.08210 (100%), 472.08454 (26%); found 471.08221 
(100%), 472.08561 (23%). 
 
(5-(4-Methoxy[2.2]paracyclophanyl))(4’-methoxyphenyl)iodonium 
hexafluorophosphate, 3-1 
 
In a 100 mL Schlenk tube, 4-methoxy-5-iodo-[2.2]paracyclophane (1.14 mmol, 
416.7 mg) was dissolved in 25 mL of distilled ether and cooled to -78 °C. To this stirred 
solution, 1.7 M t-butyl lithium (2.85 mmol, 1.68 mL) was added dropwise and the 
solution was held at -78 °C for 1 hour.  A solution of anhydrous zinc chloride (1.37 
mmol, 190.0 mg) in 10 mL of diethyl ether was added dropwise to the cold solution over 
the course of 1 h. The mixture was allowed to warm to room temperature, and the solvent 
was removed under reduced pressure. The residual solid (comprising organozinc chloride 
reagent and lithium salts) was taken up in anhydrous acetonitrile and cooled to -40 °C 
before a solution of 4-methoxyphenyl iodonium diacetate (1.89 mmol, 665.5 mg) in 
61 
 
acetonitrile (10 mL) was added in a dropwise fashion. After 1 hour at -40 °C, the mixture 
was allowed to warm to room temperature and the solvent was removed under reduced 
pressure. Deionized water and sodium hexafluorophosphate (470 mg) were added, 
followed by 50 mL of dichloromethane. The mixture was transferred to a separatory 
funnel and the organic phase was separated. The solvent was removed by rotary 
evaporation and the remaining solid was dissolved in 5 mL of dichloromethane and 
dripped into 150 mL hexanes. The precipitate was aged for one hour, collected by gravity 
filtration, and dried in vacuo to yield a colorless salt (13.0 %, 91.0 mg).
 1
H NMR 
(CD3CN, 400 MHz, 25 °C): δ 7.99 (d, 9.3 Hz, 2H), 7.07 (d, 9.2 Hz, 2H), 6.84 (d, 7.8 Hz, 
1H), 6.59- 6.69 (m, 4H), 6.11 (d, 7.9 Hz, 1H), 3.88 (s, 3H), 3.84 (s, 3H), 3.32 – 3.38 (m, 
1H), 3.06 – 3.26 (m, 6H), 2.93 – 3.00 (m, 1H).  13C NMR (CD3CN, 400 MHz, 25 °C): δ 
163.4, 156.9, 144.9, 142.3, 140.0, 138.3, 138.2, 133.7, 133.3, 133.2, 131.8, 130.4, 129.2, 
118.3, 99.3, 62.5, 55.8, 36.9, 33.8, 33.7, 31.9. 
19
F NMR (CD3CN, 400 MHz, 25 °C): δ -
72.8 (d, J = 706.9 Hz, 6F). HRMS: (HRFAB) calcd. for C24H24IO2 [M]
+
 471.0821, found 
471.0806. 
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Appendix A 
 
Common abbreviations used in this thesis 
 
PET  Positron Emission Tomography 
TMAOH Tetramethylammonium hydroxide 
TMAF Tetramethylammonium fluoride 
[
18
F]FDG 2-[
18
F]Fluoro-2-deoxy-D-glucose 
CsF  Cesium fluoride 
K2.2.2KF Kryptofix 2.2.2. KF 
CH3CN Acetonitrile 
C6H6  Benzene 
TMAPF6 Tetramethylammonium hexafluorophosphate 
F-MTEB 3-Fluoro-5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]benzonitrile 
F-DOPA 6-fluorodihydroxyphenylalanine 
TMEDA Tetramethylethyl diamine 
t-BuLi  t-Butyl Lithium 
n-BuLi  n-Butyl Lithium 
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